FdaApplication
ANDA 209920
Identifiers
- fda_app_no: ANDA209920
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2022-01-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LUBIPROSTONE | LUBIPROSTONE | 8MCG | CAPSULE;ORAL |
| LUBIPROSTONE | LUBIPROSTONE | 24MCG | CAPSULE;ORAL |
2 products